Worg Pharmaceuticals
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Building# 26 388 # Shengrong Rd, Pudong ...Phone Number
+86 2158865100Website
www.worgpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Worg Pharmaceuticals
百明信康生物技术浙江股份有限公司 is a global innovative biopharmaceutical company established in 2018, focusing on the research and development of next-generation specific immunotherapy for allergic and autoimmune diseases. The company aims to provide integrated diagnostic and treatment solutions through a revolutionary technology platform and has established R&D centers in Shanghai and Madrid. With over 10 allergy treatment and diagnostic products commercialized globally, it is actively pursuing clinical registration and commercialization in various markets, including China and Germany. 百明信康 has a robust pipeline of nearly 10 innovative projects in preclinical and clinical development.Explore more
Popular SearchesWorg Pharmaceuticals Co LtdPharmaceuticals CoWorg Pharmaceuticals百明信康生物技术（杭州）有限公司 WorgpharmaSIC Code 28,283NAICS Code 32,325Show moreWorg Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Worg Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Worg Pharmaceuticals recently announced quarterly report
Check out if Worg Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Worg Pharmaceuticals
Check if Worg Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Worg Pharmaceuticals launches new products
Worg Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Worg Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Worg Pharmaceuticals has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Worg Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Worg Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Worg Pharmaceuticals.
Worg Pharmaceuticals financials insights
Gather financial insights about Worg Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series C
$151M
Worg Pharmaceuticals Tech Stack
A closer look at the technologies used by Worg Pharmaceuticals
Worg Pharmaceuticals News & Media
Chinese clinical-stage biopharma Worg closes $152m Series C round - DealStreetAsia
Founded in 2018, Worg develops immunotherapies for the treatment of allergic and autoimmune diseases.China VC Investment List Q3 2022 – Healthcare | EqualOcean
This is part of a seven-part series on China's VC investment in Q3 2022. This series features firms spanning seven industries, including automaking, healthcare, new consumption, intelligent hardware, smart manufacturing, enterprise services and emerging technologies.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Worg Pharmaceuticals
Sign Up For FreeTo access detailed company insights
百明信康生物技术浙江股份有限公司 is a global innovative biopharmaceutical company established in 2018, focusing on the research and development of next-generation specific immunotherapy for allergic and autoimmune diseases. The company aims to provide integrated diagnostic and treatment solutions through a revolutionary technology platform and has established R&D... Read More
